搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
FiercePharma
2 小时
Klick Health swoops in to acquire life sci market access agency Peregrine
Klick Health is taking a fellow life-sci-centric agency under its wing. | Klick Health is taking a fellow life-sci-centric ...
FiercePharma
15 小时
FDA warning letter reveals quality control, data integrity issues at Viatris plant in India
In a warning letter posted online late last month, the FDA scolded Viatris over a range of production slights at the ...
FiercePharma
16 小时
FDA looks to clarify confirmatory trial mandate for accelerated approvals
In recent years, the FDA has amped up its supervision of accelerated approvals, including by requiring that confirmatory ...
FiercePharma
17 小时
Pfizer, PhRMA rank among groups pledging funding for Trump's inauguration: NYT
From condemning the Jan. 6 Capitol riots to helping fund the President-elect’s impending inauguration, recent years have seen ...
FiercePharma
20 小时
In €500M deal, Merck buys Ireland vaccines plant from CDMO WuXi Biologics
In Ireland, WuXi Biologics has sold a new vaccines plant to Merck & Co. for €500 million ($521 million). The New Jersey ...
FiercePharma
20 小时
Citius Oncology weighs strategic options on road to launching newly-approved lymphoma med
After nabbing an FDA approval last summer for its T-cell lymphoma treatment Lymphir, Citius Oncology is eyeing strategic ...
FiercePharma
21 小时
‘Ozempic’s biggest night’: GLP-1s back in Hollywood spotlight at Lilly-backed 2025 ...
Comedian Nikki Glaser, host of the 2025 Golden Globe Awards ceremony, dove right in at the start of her opening monologue: ...
FiercePharma
21 小时
Amylyx names chief commercial officer as GLP-1 receptor antagonist launch plans start ...
Amylyx Pharmaceuticals has named Dan Monahan as chief commercial officer, positioning an exec who led the U.S.
FiercePharma
21 小时
Regulatory tracker: Amgen's bispecific approved for small cell lung cancer in UK
Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...
FiercePharma
3 天
Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
FiercePharma
3 天
Roche projected to claim pharma's 2025 sales crown as Novo, Lilly climb rankings: Evaluate
The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈